<?xml version="1.0" encoding="UTF-8"?>
<p id="p0345">Numerous drugs derived from carboxylic acid under investigation are considered promising to fight COVID-19. The combination lopinavir 
 <bold>(24)</bold>/ritonavir 
 <bold>(25)</bold> (Kaletra) is the most outstanding (
 <xref rid="f0025" ref-type="fig">Fig. 5</xref> ). These are antiretroviral drugs often used in combination to treat HIV patients because ritonavir increases concentrations of lopinavir in the body. Also, the combination of both drugs is valuable given their availability in the market and the possibility of immediate prescription.
 <xref rid="b0835" ref-type="bibr">
  <sup>167</sup>
 </xref> The mechanism of action implicates protease inhibition which consequently interferes with HIV synthesis and replication.
 <xref rid="b0840" ref-type="bibr">
  <sup>168</sup>
 </xref>
</p>
